We don't know whether the most recent response to this request contains information or not – if you are SPENCER JONES please sign in and let everyone know.

Official Information Request – Medsafe’s Role and Oversight in Industrial Hemp Regulation

SPENCER JONES made this Official Information request to Ministry of Health

This request has an unknown status. We're waiting for SPENCER JONES to read a recent response and update the status.

From: SPENCER JONES

Dear Ministry of Health,

Pursuant to the Official Information Act 1982, I request the following information concerning Medsafe’s involvement in the regulation of the industrial hemp (iHemp) sector, including cannabidiol (CBD) and low-THC cannabis:

1. **Regulatory Role**
All documentation outlining Medsafe’s regulatory, compliance, or quality assurance functions related to industrial hemp, CBD, or low-THC cannabis. This includes internal policy documents, guidelines, briefing papers, risk assessments, or legislative advice prepared since 1 January 2018.

2. **Interagency Duplication or Role Clarity**
Any internal or interagency communications (including emails, meeting minutes, reports, or discussion papers) involving Medsafe and:

* Ministry for Primary Industries (MPI),
* Ministry of Business, Innovation and Employment (MBIE),
* Ministry for the Environment (MfE),
that refer to:
* overlapping roles or functions,
* shared responsibilities,
* duplicated processes or regulatory uncertainty in relation to hemp regulation.

3. **Shared Oversight Responsibilities**
Any contracts, operational procedures, or consultation reports involving Medsafe and other agencies that describe:

* joint involvement in product testing, compliance activities, or licensing,
* shared or duplicated oversight of industrial hemp or hemp-derived compounds.

4. **Performance Reviews or Evaluations**
All reviews, evaluations, or internal assessments conducted or received by Medsafe since 1 January 2018 regarding:

* the effectiveness, efficiency, or appropriateness of Medsafe’s role in the regulation of hemp products,
* any identified redundancies, inefficiencies, or jurisdictional confusion across agencies.

I request that the information be provided in electronic format, if possible. If any aspect of this request is likely to be refused, please advise me of the reason under the relevant sections of the Act.

I look forward to your response within the statutory timeframe of 20 working days.

Yours faithfully,

SPENCER JONES

Link to this

From: OIA Requests


Attachment image.png
89K Download


Kia ora Spencer

 

Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health on 19 June 2025. You requested:

 

Pursuant to the Official Information Act 1982, I request the following
information concerning Medsafe’s involvement in the regulation of the
industrial hemp (iHemp) sector, including cannabidiol (CBD) and low-THC
cannabis:

1. **Regulatory Role**
  All documentation outlining Medsafe’s regulatory, compliance, or quality
assurance functions related to industrial hemp, CBD, or low-THC cannabis.
This includes internal policy documents, guidelines, briefing papers, risk
assessments, or legislative advice prepared since 1 January 2018.

2. **Interagency Duplication or Role Clarity**
  Any internal or interagency communications (including emails, meeting
minutes, reports, or discussion papers) involving Medsafe and:

* Ministry for Primary Industries (MPI),
  * Ministry of Business, Innovation and Employment (MBIE),
  * Ministry for the Environment (MfE),
    that refer to:
  * overlapping roles or functions,
  * shared responsibilities,
  * duplicated processes or regulatory uncertainty in relation to hemp
regulation.

3. **Shared Oversight Responsibilities**
  Any contracts, operational procedures, or consultation reports involving
Medsafe and other agencies that describe:

* joint involvement in product testing, compliance activities, or
licensing,
  * shared or duplicated oversight of industrial hemp or hemp-derived
compounds.

4. **Performance Reviews or Evaluations**
  All reviews, evaluations, or internal assessments conducted or received
by Medsafe since 1 January 2018 regarding:

* the effectiveness, efficiency, or appropriateness of Medsafe’s role in
the regulation of hemp products,
  * any identified redundancies, inefficiencies, or jurisdictional
confusion across agencies.

I request that the information be provided in electronic format, if
possible. If any aspect of this request is likely to be refused, please
advise me of the reason under the relevant sections of the Act.
 

 

The reference number for your request is H2025068833. As required under
the Act, the Ministry will endeavour to respond to your request no later
than 20 working days after the day your request was
received: [1]http://www.ombudsman.parliament.nz/

 

If you have any queries related to this request, please do not hesitate to
get in touch ([2][email address]).

 

 

Ngâ mihi 
 
OIA Services Team 
[3]Ministry of Health information releases 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...

hide quoted sections

Link to this

We don't know whether the most recent response to this request contains information or not – if you are SPENCER JONES please sign in and let everyone know.

Things to do with this request

Anyone:
Ministry of Health only: